Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method

National Committee for Clinical Laboratory Standards, 1996, vol. 17

Lesher, 1992, Therapeutic agents for dermatologic fungal diseases, 229

Rex, 1997, Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections, Clin Infect Dis, 24, 235, 10.1093/clinids/24.2.235

Larone, 1995

Epstein, 1972, Griseofulvin levels in stratum corneum, Arch Dermatol, 106, 344, 10.1001/archderm.1972.01620120032006

Faergemann, 1994, Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days, Clin Exp Dermatol, 19, 121, 10.1111/j.1365-2230.1994.tb01138.x